Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Top Cited Papers
Open Access
- 1 September 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (5), 634-653
- https://doi.org/10.1086/432579
Abstract
Background. Zygomycosis is an increasingly emerging life-threatening infection. There is no single comprehensive literature review that describes the epidemiology and outcome of this disease. Methods. We reviewed reports of zygomycosis in the English-language literature since 1885 and analyzed 929 eligible cases. We included in the database only those cases for which the underlying condition, the pattern of infection, the surgical and antifungal treatments, and survival were described. Results. The mean age of patients was 38.8 years; 65% were male. The prevalence and overall mortality were 36% and 44%, respectively, for diabetes; 19% and 35%, respectively, for no underlying condition; and 17% and 66%, respectively, for malignancy. The most common types of infection were sinus (39%), pulmonary (24%), and cutaneous (19%). Dissemination developed in 23% of cases. Mortality varied with the site of infection: 96% of patients with disseminated disease died, 85% with gastrointestinal infection died, and 76% with pulmonary infection died. The majority of patients with malignancy (92 [60%] of 154) had pulmonary disease, whereas the majority of patients with diabetes (222 [66%] of 337) had sinus disease. Rhinocerebral disease was seen more frequently in patients with diabetes (145 [33%] of 337), compared with patients with malignancy (6 [4%] of 154). Hematogenous dissemination to skin was rare; however, 78 (44%) of 176 cutaneous infections were complicated by deep extension or dissemination. Survival was 3% (8 of 241 patients) for cases that were not treated, 61% (324 of 532) for cases treated with amphotericin B deoxycholate, 57% (51 of 90) for cases treated with surgery alone, and 70% (328 of 470) for cases treated with antifungal therapy and surgery. By multivariate analysis, infection due to Cunninghamella species and disseminated disease were independently associated with increased rates of death (odds ratios, 2.78 and 11.2, respectively). Conclusions. Outcome from zygomycosis varies as a function of the underlying condition, site of infection, and use of antifungal therapy.Keywords
This publication has 404 references indexed in Scilit:
- Combined Antifungal Treatment of Visceral Mucormycosis with Caspofungin and Liposomal Amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheterEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Cutaneous zygomycosis caused byAbsidia corymbifera in a leukemic patientMycopathologia, 1995
- Gastrointestinal mucormycosis causing an acute abdomen in the immunocompromised pediatric patient—Three casesJournal of Pediatric Surgery, 1994
- Treatment of deep mycoses with liposomal amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Cutaneous mucormycosis resembling superficial granulomatous pyoderma in an immunocompetent hostJournal of the American Academy of Dermatology, 1993
- Massive renal infarction due to mucormycosis in an AIDS patientInfection, 1992
- Primary cutaneous mucormycosis in a healthy young girl: Report of a case caused by Mucor hiemalis WehmerJournal of the American Academy of Dermatology, 1991
- Prosthetic mitral valve mucormycosis caused by Mucor speciesInternational Journal of Cardiology, 1987
- Mycosis mucorinaVirchows Archiv, 1885